another news portal
While extremely rare, encephalopathy (a condition affecting brain function) triggered by mutations in the UBA5 gene has devastating impacts, with affected individuals reaching few developmental
Diabetes care, rehab centres, end-of-life services and talking therapies at risk in England.
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline that includes an AI-assisted scientific review pilot.
The United States will cut $50 million in aid a year to the southern African country of Zambia because of the “systematic” theft of medicines
Spring is a miserable season for those with seasonal allergies. There are effective drug- and non-drug measures that can control most symptoms effectively. The post
The incidence of infection by Mycobacterium abscessus, is increasing in patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other chronic pulmonary diseases, leading
Researchers at Umeå University, Sweden, and Michigan State University, USA, have discovered a type of molecule that can kill chlamydia bacteria but spare bacteria that
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune
A new U.S. government study provides the most complete picture yet of early-onset cancers, defined as cancer diagnosed before age 50
Rapidly rising rates of heart disease across Southeast Asia, East Asia and Oceania are being driven by localized consequences of industrialization and rapid economic growth
A brief spell of talking therapy with a general practitioner reduces symptoms of post-traumatic stress disorder (PTSD) for survivors of critical illness, finds a trial
A next-generation “armored” CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of
A Danish cohort study investigated whether long-term exposure to repeated monthly peaks of fine particulate matter (PM2.5) raises the risk of major adverse cardiovascular events.
